For 54 patients (27%), the expression of MSX2 was exclusively cytoplasmic, 76 patients (38%) had both cytoplasmic and nuclear staining, for 27 patients (13.5%) only nuclear MSX2 expression was detectable and 42 tumours (21.5%) did not express MSX2. This evidence concerns the gene MSX2 and neoplasm.